FMP
Talis Biomedical Corporation
TLIS
NASDAQ
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.
9.2 USD
0.1502 (1.63%)
About
ceo
Mr. Robert Kelley MBA
sector
Healthcare
industry
Medical - Devices
website
https://talisbio.com
exchange
NASDAQ
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was inc...
CIK
0001584751
ISIN
US87424L2079
CUSIP
87424L108
Address
230 Constitution Drive
Phone
650 433 3000
Country
US
Employee
99
IPO Date
Feb 12, 2021
Summary
CIK
0001584751
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
87424L108
ISIN
US87424L2079
Country
US
Price
9.2
Beta
1.74
Volume Avg.
9.17k
Market Cap
16.74M
Shares
-
52-Week
4.35-9.32
DCF
0.03
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.27
P/B
-
Website
https://talisbio.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest TLIS News
It looks like there's no news available.
